 |
|
Regional Differences in Access to Clinical Trials for Cancer in Korea
Woorim Kim, Seongkyeong Jang, Yoon Jung Chang
Qual Improv Health Care. 2021;27(1):20-25. Published online 2021 Jun 30 DOI: https://doi.org/10.14371/QIH.2021.27.1.20
|
|
Citations to this article as recorded by
 Analysis of the distribution of trial sites in South Korea using social network analysis
Ki Young Huh, Kyung-Sang Yu, Ildae Song
Translational and Clinical Pharmacology.2023; 31(1): 1. CrossRef The effect of fragmented cancer care and change in nurse staffing grade on cancer patient mortality
Kyu‐Tae Han, Seungju Kim
Worldviews on Evidence-Based Nursing.2023; 20(6): 610. CrossRef Cancer-free Life Expectancy in Small Administrative Areas in South Korea and Its Associations with Regional Health Insurance Premiums
Eunjeong Noh, Hee-Yeon Kang, Jinwook Bahk, Ikhan Kim, Young-Ho Khang
Journal of Korean Medical Science.2021;[Epub] CrossRef Trends of clinical trials from 2017 to 2019 in Korea: an integrated analysis based on the Ministry of Food and Drug Safety (MFDS) and the Clinical Research Information Service (CRIS) registries
Ki Young Huh, Kyung-Sang Yu, Hyeong-Seok Lim, Hyungsub Kim
Translational and Clinical Pharmacology.2021; 29(4): 186. CrossRef
|